PCT Guided Stopping of Antibiotic Therapy in Children With Sepsis
Procalcitonin Level Guided Cessation of Antibiotic Therapy in Children With Sepsis: A Randomized Controlled Trial
1 other identifier
interventional
561
1 country
2
Brief Summary
The investigators' objective is to compare the risk of treatment failure\* in children admitted to the pediatric intensive care unit (PICU) with sepsis and managed by procalcitonin guided therapy for stopping of antibiotics ('PCT- guided therapy' group) with those managed with standard practices based on the evidence based guidelines ('control' group). Children with suspected or proven sepsis will be randomized to the PCT guided group or the standard practices group and will be followed up for the outcome measures that include treatment failure and mortality. The investigators plan to enroll 560 patients over a period of 3 years. The investigators believe that the proposed study will provide the answer to reducing unnecessary antibiotic usage in the PICU without causing any harm to the patient in the form of treatment failure and/or mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable sepsis
Started Oct 2019
Longer than P75 for not_applicable sepsis
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2017
CompletedFirst Posted
Study publicly available on registry
January 3, 2018
CompletedStudy Start
First participant enrolled
October 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedMarch 3, 2025
February 1, 2025
3.4 years
August 18, 2017
February 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Treatment failure
The primary outcome measure would be treatment failure\* (defined as growth of one or more of the initial causative organism(s) from a second sample taken within 48 hours after stopping antibiotics and/ or clinical signs or symptoms of infection) within 7 days of stoppage of antibiotics.
From day of stopping first course of antibiotic therapy till day 7 after stopping antibiotics
Secondary Outcomes (3)
Proportion clinically cured
From day of stopping first course of antibiotic therapy till day 7 of stopping therapy
Antibiotic free days
Till day 28 of hospital stay
Mortality
Till death or day 28 whichever is earlier
Study Arms (2)
PCT group
EXPERIMENTALPCT group
Standard practice group
NO INTERVENTIONNo intervention
Interventions
In this group antibiotic therapy will be stopped based on serial PCT measurements starting from admission.
Eligibility Criteria
You may qualify if:
- Children 2 month to 17 years admitted to the ICU and already receiving antibiotics for suspected or proven sepsis (defined as systemic inflammatory response syndrome or SIRS due to infection) and children who are started on antibiotics in the ICU for suspected or proven sepsis will be included.
You may not qualify if:
- Children receiving antibiotics more than 24 hours before presentation
- Children with severe immunosuppression (CD4 count of less than 200 cells/mm3, neutropenic patients (\<500 neutrophils/ml)) other than corticosteroid use
- Children admitted for post-op observation
- Children with an estimated length of stay less than 24 hrs
- Children with underlying co-morbidities with possible imminent death
- Children whose parents refuse to give an informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
St Johns Medical College and Hospital
Bengaluru, Karnataka, 560034, India
PGIMER
Chandigarh, India
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
S K Kabra, MD
All India Institute of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 18, 2017
First Posted
January 3, 2018
Study Start
October 21, 2019
Primary Completion
February 28, 2023
Study Completion
February 28, 2023
Last Updated
March 3, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share